A recent study published yesterday out of Singapore showed that 36 patients treated with a surgically implanted, membrane impregnated with culture expanded, mesenchymal stem cells did better than those treated with autologous chondrocyte implantation. ACI is a procedure where cartilage cells are implanted into a hole in the cartilage, requiring one surgery to harvest cartilage and one to re-implant that cartilage. In addition, ACI is a big surgery, where a piece of the fibrous covering of bone is cut open and the cartilage cells placed under this “flap” and the flap sewn down. 36 patients underwent each procedure (total 72 patients), with both groups improving. However, the improvement for ACI followed the same type of improvement parameters seen with micro fracture surgery, with patients under 45 years of age improving more than those over 45 years of age. With the stem cell treatment, the older patients did as well as the younger patients. In addition, there were fewer complications in the stem cell group and this group needed one fewer surgery (as the stem cells were taken by needle from the back of the hip, not surgically harvested from the knee). This study marks the first head to head comparison of traditional surgery (ACI) vs. stem cell therapy (in this case surgically implanted adult stem cells). The data shown here (that older patients did as well as younger patients) is also consistent with an analysis of our knee dataset (n=112) that we will be submitting for publication. While our cells were implanted via a needle, I’m sure the future holds promise for blended surgical and cell based procedures as well as injection procedures for patients with knee arthritis.
*DISCLAIMER: Like all medical procedures, Regenexx® Procedures have a success and failure rate. Patient reviews and testimonials on this site should not be interpreted as a statement on the effectiveness of our treatments for anyone else.
Providers listed on the Regenexx website are for informational purposes only and are not a recommendation from Regenexx for a specific provider or a guarantee of the outcome of any treatment you receive.
About the Author
Christopher J. Centeno, M.D. is an international expert and specialist in regenerative medicine and the clinical use of mesenchymal stem cells in orthopedics. He is board certified in physical medicine as well as rehabilitation and in pain management through The American Board of Physical Medicine and Rehabilitation.…